Inpharma Weekly

, Volume 1076, Issue 1, pp 5–6 | Cite as

Multiorgan failure in the critically ill: outcomes and costs

  • Larry Prescott
Newsletter Article


In these days of serious healthcare cost containment, there is considerable concern about the relationship between outcome and cost in critically ill patients with multiple organ failure. Even though a large number of these persons die and multiple organ failure is expensive to treat, an examination of the long-term outcomes and direct costs of treatment in specific groups of patients with multiple organ failure has demonstrated that this cost can be reasonable in terms of cost per life-year gained and even quality adjusted life-years gained. Dr David J Bihari discussed these issues at the 26th Educational and Scientific Symposium of the Society of Critical Care Medicine [ San Diego, California, February 1997 ].


Multiple Organ Failure Vasoactive Drug Hospital Survivor Scientific Symposium Skeletal Muscle Wasting 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Adis International Ltd 1997

Authors and Affiliations

  • Larry Prescott

There are no affiliations available

Personalised recommendations